Skip to Content

Lacidipine

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C08CA09

CAS registry number (Chemical Abstracts Service)

0103890-78-4

Chemical Formula

C26-H33-N-O6

Molecular Weight

346

Therapeutic Categories

Antihypertensive agent

Calcium channel blocker

Chemical Name

3,-5-Pyridinedicarboxilic acid,4-[2-[3-(1,1-dimetyletoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimetyl-,dietyl ester, (E)-

Foreign Names

  • Lacidipinum (Latin)
  • Lacidipin (German)
  • Lacidipine (French)
  • Lacidipino (Spanish)

Generic Names

  • Lacidipina (OS: DCIT)
  • Lacidipine (OS: USAN, DCF, BAN, JAN)
  • GR 43659 X (Glaxo) (IS)
  • GX 1048 (Glaxo) (IS)
  • Lacidipine (PH: BP 2018)

Brand Names

  • Aponil
    Glaxo Allen, Italy
  • Lacibloc
    Ultramed, Philippines
  • Lacicard
    Aristopharma, Bangladesh
  • Lacidac
    Delta Pharma, Egypt
  • Lacidipin Belupo
    Belupo, Croatia (Hrvatska)
  • Lacidipin Double-E Pharma
    Copharma, Denmark
  • Lacidipin Teva
    Teva, Denmark; Teva, Lithuania
  • Lacidipina Rivopharm
    Rivopharm, Italy
  • Lacidipine
    Doc Generici, Malta; Dr. Reddy's, United Kingdom; Rivopharm UK, United Kingdom
  • Lacidipine Double-E Pharma
    Alpha-Medical, Croatia (Hrvatska); Double-E Pharma, Lithuania; Double-E Pharma Limited, Netherlands
  • Lacidipine Teva
    Teva Nederland, Netherlands; Teva Pharmaceuticals, Poland
  • Lacidipino Teva
    Teva, Spain
  • Lacimen
    GlaxoSmithKline, Spain
  • Lacipil
    Glaxo, Bulgaria; Glaxo Group, Romania; Glaxo Wellcome, Portugal; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Estonia; GlaxoSmithKline, Egypt; GlaxoSmithKline, Spain; GlaxoSmithKline, Georgia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline A.B.E.E., Greece; GlaxoSmithKline Brasil, Brazil; GSK, Czech Republic; GSK, Slovakia; Wellcome Limited, Bosnia & Herzegowina; GlaxoSmithKline China Investment, China
  • Lacipil 2 mg
    GlaxoSmithKline, Hungary
  • Lacipil 4 mg
    GlaxoSmithKline, Hungary
  • Lacirex
    Laboratori Guidotti, Italy
  • Lacitens
    GlaxoSmithKline A.B.E.E., Greece
  • Lacivas
    Sun, India
  • Lacydyna
    Alpha-Medical, Croatia (Hrvatska); Rivopharm, Poland
  • Ladip
    Glaxo Allen, Italy
  • Lanidiem
    Samil, South Korea
  • Lapixen
    Biofarm, Poland
  • Lasyn
    Synmosa, Taiwan
  • Lodipine
    Egyphar, Egypt
  • Midotens
    Boehringer Ingelheim, Mexico
  • Monopin
    Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska)
  • Motens
    Boehringer Ingelheim, Greece; Boehringer Ingelheim España, Spain; GlaxoSmithKline UK, United Kingdom
  • Prelum
    double-e pharma, Latvia
  • Sileping
    Hayao Pharmaceutical Group Holding, China
  • Sinopil
    GlaxoSmithKline, India
  • Viapres
    Crinos, Italy

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide